View:
Download DOC
Download PDF
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Ruiz-Caban Wilfredo
(Last) (First) (Middle)
C/O CONMED CORPORATION
525 FRENCH ROAD
(Street)
UTICA NY 13502
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CONMED CORP [ CNMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP QA, RA and Operations
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2016
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Rsus (restricted Stock Units) $0 03/01/2016 A 1,500 (1) 03/01/2026 Common Stock 1,500 $0 1,500 D
Options To Purchase Common Stock $39.87 03/01/2016 A 29,200 (2) 03/01/2026 Common Stock 29,200 $0 29,200 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
2. The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Sarah M. Oliker for Wilfredo Ruiz-Caban by Power of Attorney 03/03/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.


EXHIBIT 24

POWER OF ATTORNEY


Know all by these presents,that the undersigned hereby constitutes and
appoints Daniel S. Jonas and Sarah  M. Oliker, signing singly, the
undersigned's true and lawful attorney-in-fact  to:

(1)         prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and Exchange
Commission (the  "SEC")  a  Form  ID,  including  amendments   thereto,
and  any  other  documents necessary or appropriate  to obtain codes and
passwords enabling the undersigned  to make electronic filings with the SEC
of reports required  by Section 16(a) of the Securities Exchange  Act
of 1934 or any rule or regulation of the SEC;

(2)         execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer  and/or director of (the "Company"), Forms 3, 4, and 5
in accordance  with Section 16(a) of the Securities Exchange Act of 1934 and
the rules thereunder,  and any other forms or reports the undersigned  may be
required  to file in connection  with the undersigned's ownership,
acquisition, or disposition of securities of the Company;

(3)         do and  perform  any and all acts for and on  behalf of the
undersigned  which  may be necessary or desirable to complete and execute
any such Form 3, 4, or 5, or other form or report, including executing Form
144s, lock-ups, internal corporate  forms for the exercise of SARs or options
and the like,  and to timely file such form or report with the United States
Securities and Exchange Commission  and any stock exchange or similar
authority; and

(4)         take any other action of any type whatsoever in connection
with the foregoing  which, in the opinion of such attorney-in-fact, may
be of benefit  to, in the  best interest of, or  legally  required  by,
the  undersigned,  it being understood  that the documents  executed  by
such  attorney-in-fact  on  behalf of the  undersigned  pursuant to this
Power of Attorney shall be in such form and shall contain such terms and
conditions  as such attorney-in-fact  may approve in such attorney-in-fact's
discretion.

	The undersigned hereby grants to each such attorney-in-fact  full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done  in the exercise of any of the
rights and powers herein granted, as fully to all intents and  purposes as the
undersigned  might or could  do  if personally  present, with  full
power of substitution or revocation,  hereby ratifying and confirming
all that such attorney-in-fact,  or such attorney-in-fact's substitute
or substitutes, shall lawfully do or cause to be done  by virtue  of this
power of attorney  and the  rights and  powers  herein granted . The
undersigned acknowledges that the foregoing  attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor is
the Company assuming, any of the undersigned's responsibilities to comply
with Section  16 of the Securities  Exchange Act of 1934.

	This Power of Attorney shall remain in full force and effect until the
undersigned  is no longer required to file Forms 3, 4, and 5 with respect
to the undersigned 's holdings of and transactions  in securities issued by
the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.

	IN WITNESS  WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 8th day of September 2015.


					/s/Wilf Ruiz-Caban